Aesculap's spinal plating system cleared by FDA
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for Aesculap Implant Systems' S4 cervical occipital plating system. The product is designed to promote spinal fusion in patients with degenerative disc disease or fracture. It is intended for use at the cervical and thoracic levels of the spine, and the occipito-cervico-thoracic junction.